Rediscussion on 10 hot issues of endocrine therapy for breast cancer

王晓迪; 江泽飞

doi:10.19401/j.cnki.1007-3639.2017.10.010

您当前的位置：

首页 >

文章列表页 >

Rediscussion on 10 hot issues of endocrine therapy for breast cancer

更新时间：2025-12-31

- Rediscussion on 10 hot issues of endocrine therapy for breast cancer
- China Oncology Vol. 27, Issue 10, Pages: 822-828(2017)
- 作者机构：
  
  1. 清华大学附属北京清华长庚医院肿瘤内科,北京,102218
  2. 军事医学科学院附属医院乳腺肿瘤科,北京,100071
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.10.010
  CLC：
- Published Online：05 December 2017，
  
  Published：05 December 2017
- 稿件说明：
移动端阅览
王晓迪,江泽飞. 再议乳腺癌内分泌治疗10项热点问题[J]. 中国癌症杂志, 2017, 27(10): 822-828.

王晓迪, 江泽飞. Rediscussion on 10 hot issues of endocrine therapy for breast cancer[J]. China Oncology, 2017, 27(10): 822-828.
王晓迪,江泽飞. 再议乳腺癌内分泌治疗10项热点问题[J]. 中国癌症杂志, 2017, 27(10): 822-828. DOI： 10.19401/j.cnki.1007-3639.2017.10.010.

王晓迪, 江泽飞. Rediscussion on 10 hot issues of endocrine therapy for breast cancer[J]. China Oncology, 2017, 27(10): 822-828. DOI： 10.19401/j.cnki.1007-3639.2017.10.010.

摘要

近年来，乳腺癌的内分泌治疗数据更新较多，使临床工作中产生了新的问题，带来了新的思考。该文就绝经前乳腺癌患者内分泌治疗中卵巢功能抑制的适宜患者的选择，卵巢功能抑制联合口服内分泌药物方案的选择，内分泌治疗过程中不良反应管理，乳腺癌患者的生育问题和延长内分泌治疗等10项早期乳腺癌内分泌治疗中的热点问题，结合数据和笔者的临床经验进行再次阐述。

Abstract

With the data generated in recent years

the new issues encountered by practicing physicians in endocrine therapy for breast cancer have been warmly discussed. Meanwhile

the hot discussion brought us new ways of thinking. Based on the new evidence and clinical experience

this article rediscussed the application of ovarian function suppression (OFS) and the appropriate choice of endocrine drugs combining with OFS. We focused on the management of the adverse effects in patients using OFS plus aromatase inhibitor

the fertility problems and prolonged endocrine treatment in breast cancer patients.

关键词

Keywords

references

Views

4395

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

Advances in understanding the correlation between lymph node metastasis and immune regulation in breast cancer through spatiotemporal transcriptomic analysis

Expert consensus on diagnosis and treatment of hematologic malignancies with solid tumors (2025 version)

MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma

Related Author

The Society of Breast Cancer China Anti-Cancer Association

Breast Oncology Group of the Oncology Branch of the Chinese Medical Association

WANG Xiaowen

BI Zhao

LING Yuanchao

ZHENG Luming

WANG Yongsheng

QIU Pengfei

Related Institution

The 960th Hospital of PLA

Department of Breast Cancer Center, Shandong First Medical University Affiliated Tumor Hospital (Shandong Provincial Institute of Cancer Prevention and Treatment, Shandong Cancer Hospital)

Shandong First Medical University (Shandong Provincial Academy of Medical Sciences)

Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Radiation Oncology, Shanghai Clinical Research Center for Radiation Oncology, Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰